Hints and tips:
Related Special Reports
Companies have yet to provide investors with convincing post-pandemic strategies
The FT’s fourth annual ranking of the region’s businesses by revenue growth. Plus: companies with the ‘last-mover advantage’; cannabis corporations on the rise; is Moderna a one trick pony?
...“The USA and the EU must see each other as strategic partners rather than zero-sum competitors in raising global competitiveness and tackling global challenges,” he said....
...Adalytics created a list of those hit, which includes dozens of leading brands such as JPMorgan Chase and Johnson & Johnson, as well the US Department of Health & Human Services....
...The country’s National Institute for Health and Care Excellence, the public health body, recommends the drug be used only for people with serious underlying health conditions such as cancer and HIV or recipients...
...In PFAS detection and testing, the current market, estimated by BofA’s Life Sciences & Diagnostic Tools analysts, is $175-225M and growing at 10-15% annually....
Regulator authorises treatment for sickle cell disease and beta thalassaemia
Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments
...Biotech beauty products are increasingly filling our bathroom cabinets; the science may have been used in a simple way for decades, but new innovations are driving considerable change....
...The findings will raise concerns about the effectiveness of antiviral drugs to treat Covid-19 as health authorities prepare for a busy autumn after a rise in cases driven by Omicron subvariants with a large...
...Given your briefs in health and science, I just wanted to give you an early sight of a paper we are putting out — an AI manifesto for the NHS. We’ve called it Help is on the WAI....
...Roivant Sciences, which has a portfolio of companies, was founded in 2014 by Vivek Ramaswamy, who is now running for US president....
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...“Vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalisation and death,” said Peter Marks, director of the FDA’s Center for...
...For many farmers, regenerative agriculture is more to do with the health of their land than of their bank balances....
...Results were published on Thursday in the journal Science....
...“Thaysen is a top leader at one of the top five life science companies and is well known by the life sciences and technology investor base . . . which should help on the communication front.”...
...He explores six mental health disciplines that constitute a more modern way to think strategically in the new global business environment....
...Filings show the company has been very slightly understating the kids’ total compensation for several years after missing additional health premiums: It’s not the only reporting error Skechers appears to...
BNP Paribas joins environmentalists in pressing companies to run toxin tests with synthetic substances
...The high price of the drugs — lecanemab is priced at $26,500 per year — and tough restrictions imposed by the US government on reimbursement by publicly funded health schemes for amyloid-reducing treatments...
Pharmaceutical and biotech deals are rebounding after a dip last year
...of the FDA’s Center for Tobacco Products’ Office of Science....
...Some emerging health science companies aspire to be the next Amgen, which has a market capitalisation of $120bn....
...Geraldine Thomas, a radiation health expert at Imperial College London who has visited Fukushima five times since the accident, agreed....
International Edition